Health Catalyst, Inc

Item 5.07. Submission of Matters to a Vote of Security Holders. On July 16, 2026, Health Catalyst, Inc. (the “Company”) held its annual meeting of stockholders (the “Annual Meeting”). The Company’s stockholders voted on four proposals at the Annual Meeting, each of which is described in greater detail in the Company’s definitive proxy statement filed with the U.S. Securities and Exchange Commission on June 3, 2026. The number of shares of the Company's common stock entitled to vote at the Annual Meeting was 73,894,020. The number of shares of the Company’s common stock present or represented by valid proxy at the Annual Meeting was 54,417,854. The final voting results with respect to each such proposal are set forth below. Proposal 1 - Election of Directors The Company’s stockholders elected each of the two persons named below to serve as a Class I director of the Company to serve a three-year term expiring at the 2029 annual meeting of the stockholders or until their successors are duly elected and qualified, subject to their earlier resignation or removal. The results of such vote were as follows: Director Name Votes For Votes Withheld Broker Non-Votes ──────────────────────────────────────────────────────────────────────────── Justin Spencer 41,161,528 926,172 12,330,154 Mathew Arens 40,617,062 1,470,638 12,330,154 Proposal 2 - Ratification of the Appointment of the Company’s Independent Registered Public Accounting Firm The Company’s stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The results of such vote were as follows: Votes For Votes Against Abstentions ────────────────────────────────────────────────── 54,389,755 26,050 2,049 Proposal 3 - Advisory, Non-Binding Vote to Approve the Compensation of the Company’s Named Executive Officers The stockholders approved the advisory, non-binding proposal to approve the compensation of the Company’s named executive officers. The results of such vote were as follows: Votes For Votes Against Abstentions Broker Non-Votes ──────────────────────────────────────────────────────────────────────── 40,369,051 992,493 726,156 12,330,154 Proposal 4 - To Approve the Restatement of the Company's Amended and Restated Certificate of Incorporation to Phase Out the Classified Board Structure The stockholders did not approve the proposal to restate the Company's Amended and Restated Certificate of Incorporation to phase out the classified board structure and provide that all directors elected at or after the Company's 2029 annual meeting of stockholders be elected on an annual basis. The results of such vote were as follows: Votes For Votes Against Abstentions Broker Non-Votes ──────────────────────────────────────────────────────────────────────── 41,751,707 335,034 959 12,330,154